WELLS FARGO & COMPANY/MN
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in LCTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$28,339
-$1,615 QoQ
Shares Held
17,937
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. LCTX ranks #261 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in LCTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,339 | 17,937 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $29,954 | 17,937 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $47,574 | 28,151 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,322 | 27,827 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $51,049 | 113,446 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $47,446 | 94,894 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $64,942 | 71,367 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $67,441 | 67,441 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $89,355 | 60,376 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $66,440 | 60,955 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $61,562 | 52,172 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $112,600 | 79,859 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $40,344 | 26,896 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $31,530 | 26,950 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,221 | 5,507 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,437 | 8,505 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $312,634 | 203,010 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,285,860 | 524,841 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,775,197 | 704,444 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,046 | 10,543 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $22,636 | 9,633 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $231,124 | 131,322 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $121,480 | 129,236 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $134,936 | 155,101 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $249,306 | 300,371 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||